Manipulation of T cell response to tumors by targeting on costimulatory pathway.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Leukemia

• Publication date

  1997-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9209456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Costimulation and tolerance in T cell immunotherapy

  2006cites this paper
• Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies.

  2005cites this paper
• The novel chelator lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA) promotes stable binding of His-tagged proteins to liposomal membranes: potent anti-tumor responses induced by simultaneously targeting antigen, cytokine and costimulatory signals to T cells.

  2005cites this paper
• Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?

  2004cites this paper
• Decreased expression of B7 costimulatory molecules and major histocompatibility complex class‐I in human hepatocellular carcinoma

  2004cites this paper
• Immunotherapy of Cancer by Active Vaccination: Does Allogeneic Bone Marrow Transplantation after Non-Myeloablative Conditioning Provide a New Option?

  2003cites this paper
• A novel approach for modifying tumor cell‐derived plasma membrane vesicles to contain encapsulated IL‐2 and engrafted costimulatory molecules for use in tumor immunotherapy

  2002cites this paper
• Autocrine costimulation: Tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7–anti-CEA diabody fusion protein

  2002cites this paper
• Specific Immunotherapy of Cancer in Elderly Patients

  2001cites this paper
• Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS.

  2000cites this paper
• Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelator Lipids: A Potentially Convenient Approach in Cancer Vaccine Development1

  2000cites this paper
• Co-stimulatory molecules B7-1 and B7-2 as experimental therapeutic targets

  1999cites this paper
• The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation.

  1999cites this paper
• Molecular characterization of U937‐dependent T‐cell co‐stimulation

  1999cites this paper
• Cancer therapy: new concepts on active immunization.

  1999cites this paper